Latest News "Trillium to Commence Clinical Testing of TTI-1612 in Patients with Interstitial Cystitis/Bladder Pain Syndrome" go »
Trillium Therapeutics Inc. (TTI) is a private research and development
biopharmaceutical company with two main areas of focus: cytoprotection and immune regulation.
